Moreover, our previous study found that Yinchenhao decoction (YCHD), known as an anti-inflammatory and choleretic agent, may also be a potential therapy for AP through pro-apoptosis, anti-inflammation, anti-oxidation, and regulation of lipid metabolism partially via regulating the NF-kB/PPARγ signaling pathway (Xiang et al., 2016). This evidence concerns the gene NFKB1 and alkaline phosphatase measurement.